CoChat

Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis

Open access
Steele, Keith E., Tan, Tze Heng, Korn, René, Dacosta, Karma, Brown, Charles, Kuziora, Michael, Zimmermann, Johannes, Laffin, Brian, Widmaier, Moritz, Rognoni, Lorenz, Cardenes, Ruben, Schneider, Katrin, Boutrin, Anmarie, Martin, Philip, Zha, Jiping, Wiestler, Tobias · 2018 · Journal for ImmunoTherapy of Cancer
Cited by 97

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Background Immuno-oncology and cancer immunotherapies are areas of intense research. The numbers and locations of CD8+ tumor-infiltrating lymphocytes (TILs) are important measures of the immune response to cancer with prognostic, pharmacodynamic, and predictive potential. We describe the development, validation, and application of advanced image analysis methods to characterize multiple immunohistochemistry-derived CD8 parameters in clinical and nonclinical tumor tissues. Methods Commercial resection tumors from nine cancer types, and paired screening/on-drug biopsies of non–small-cell lung carcinoma (NSCLC) patients enrolled in a phase 1/2 clinical trial investigating the PD-L1 antibody therapy durvalumab (NCT01693562), were immunostained for CD8. Additional NCT01693562 samples were immunostained with a CD8/PD-L1 dual immunohistochemistry assay. Whole-slide scanning was performed, tumor regions were annotated by a pathologist, and images were analyzed with customized algorithms using Definiens Developer XD software. Validation of image analysis data used cell-by-cell comparison to pathologist scoring across a range of CD8+ TIL densities of all nine cancers, relying primarily on 95% confidence in having at least moderate agreement regarding Lin concordance correlation coefficient (CCC = 0.88–0.99, CCC_lower = 0.65–0.96). Results We found substantial variability in CD8+ TILs between individual patients and across the nine types of human cancer. Diffuse large B-cell lymphoma had several-fold more CD8+ TILs than some other cancers. TIL densities were significantly higher in the invasive margin versus tumor center for carcinomas of head and neck, kidney and pancreas, and NSCLC; the reverse was true only for prostate cancer. In paired patient biopsies, there were significantly increased CD8+ TILs 6 weeks after onset of durvalumab therapy (mean of 365 cells/mm2 over baseline; P = 0.009), consistent with immune activation. Image analysis accurately enumerated CD8+ TILs in PD-L1+ regions of lung tumors using the dual assay and also measured elongate CD8+ lymphocytes which constituted a fraction of overall TILs. Conclusions Validated image analysis accurately enumerates CD8+ TILs, permitting comparisons of CD8 parameters among tumor regions, individual patients, and cancer types. It also enables the more complex digital solutions needed to better understand cancer immunity, like analysis of multiplex immunohistochemistry and spatial evaluation of the various components comprising the tumor microenvironment. Trial registration ClinicalTrials.gov identifier: NCT01693562. Study code: CD-ON-MEDI4736–1108. Interventional study (ongoing but not currently recruiting). Actual study start date: August 29, 2012. Primary completion date: June 23, 2017 (final data collection date for primary outcome measure).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40425-018-0326-x

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 97

Metadata

Authors
Steele, K. E., Tan, T. H., Korn, R., Dacosta, K., Brown, C., Kuziora, M., Zimmermann, J., Laffin, B., Widmaier, M., Rognoni, L., Cardenes, R., Schneider, K., Boutrin, A., Martin, P., Zha, J., & Wiestler, T.
Venue
Journal for ImmunoTherapy of Cancer
Publisher
BMJ
Published
2018-03-06
Volume
6
Issue
1
Pages
20-20
ISSN
2051-1426 (ISSN-L)
OpenAlex
W2797608722
Cited by
97
References
12
FWCI
4.21
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis. https://app.cochat.ai/papers/10.1186/s40425-018-0326-x
The paper
Steele, K. E., Tan, T. H., Korn, R., Dacosta, K., Brown, C., Kuziora, M., Zimmermann, J., Laffin, B., Widmaier, M., Rognoni, L., Cardenes, R., Schneider, K., Boutrin, A., Martin, P., Zha, J., & Wiestler, T. (2018). Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1186/s40425-018-0326-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.